SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019Diversity of HIV-1 Subtypes in Russia 2009-2019 - Konstantin GromovView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019Outcomes for Hepatitis B Vaccination Among HIV-Infected Adults in Georgia - Shorena DvaliView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019HCV Prevalence and Associated Factors Among People who Inject Drugs (PWID): Baseline Results of Georgian PWID Cohort Study - Ketevan ShermadiniView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019Management of Hepatitis C in Primary Healthcare in the Country of Georgia - Akaki AbutidzeView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019The New Tendencies in HIV and HCV Epidemics in Central Region of Ukraine - Tetiana KovalView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019Integrated Testing for HIV, Hepatitis, and STIs - Dorthe Raben, MScView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019Epidemiology of HIV in the Baltic Countries (Estonia, Latvia, Lithuania) - Saulius ČaplinskasView Slideset
MPMiłosz ParczewskiMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019PrEP and STI Testing in CEE: What are the Barriers, What Works? - Miłosz Parczewski, MD, PhDView Slideset
PKPavel KhaykinMDSlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019Switching to Second Line HIV Therapy - Pavel Khaykin, MDView Slideset
TKTetiana KyrychenkoMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019Virological Efficacy of First-Line Regimens, Resistance Profile and Factors Influencing Adherence to ART in Clinical Practice in Ukraine - Tetiana KyrychenkoView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2019The Prevalence of Mutations of the Hepatitis C Virus, Associated with Drug Resistance to Inhibitors of Protein NS5A Among Patients of the Republic of Belarus - Elena GasichView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 201907_BoevaView Slideset
